Clinical trial Recruiting at 5 sites Interventional Ages 18 to 85

Comparing minimal invasive extracorporeal circulation to conventional cardiopulmonary bypass in heart surgery

Official title: Minimally Invasive Extracorporeal Circulation Versus Conventional Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery (MiECS): a Randomised Controlled Trial

Run by Aristotle University Of Thessaloniki · NCT05487612 · Data updated 2026-11-12

This study is testing if a new heart surgery method called minimal invasive extracorporeal circulation can help patients avoid serious complications better than the traditional method.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment1300 (estimated)
SponsorAristotle University Of Thessaloniki
Academic / other
Locations13 sites (Toronto and 12 other locations)
StatusRecruiting
StartedMay 26, 2022
Main results expectedDecember 31, 2028
Study endsMarch 31, 2029
Registry record updatedMarch 30, 2026
Trial IDNCT05487612 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients scheduled for elective or urgent coronary artery bypass grafting or aortic valve replacement who do not have contraindications for blood transfusions.

Probably not a fit

Patients requiring emergency surgery, major aortic surgery, or those with specific blood disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of minimal invasive extracorporeal circulation (MiECC) compared to conventional cardiopulmonary bypass (cCPB) in patients undergoing cardiac surgery, specifically coronary artery bypass grafting and aortic valve replacement. It aims to determine if MiECC can reduce serious postoperative complications such as death, myocardial infarction, and acute kidney injury. The trial is multicenter and randomized, involving several hospitals and led by a prominent research unit in Greece. The primary focus is on assessing the incidence of complications within 30 days post-surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery outcomes for patients undergoing cardiac surgery.

How similar studies have gone: While previous studies on MiECC have been limited and varied in quality, this trial aims to provide robust evidence on its effectiveness compared to cCPB.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients undergoing any elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or CABG+AVR surgery using extracorporeal circulation without circulatory arrest.

Exclusion Criteria:

* Requirement for emergency or salvage operation.
* Requirement for major aortic surgery (e.g. aortic root replacement).
* Contraindication or objection (e.g. Jehovah's Witnesses) to transfusion of blood products.
* Congenital or acquired platelet, red cell or clotting disorders (patients with iron deficient anaemia will not be excluded).
* Inability to give informed consent for the study (e.g. learning or language difficulties).

Where it's running

  • Perfusion Services University Health Network, Toronto General Hospital
    Toronto, Canada
    Recruiting
  • Cardiothoracic Department AHEPA University Hospital
    Thessaloniki, Greece
    Recruiting
  • Department of Cardiac Surgery GVM Anthea Hospital
    Bari, Italy
    Recruiting
  • Department of Cardiovascular Surgery, Izmir Bakırçay University, Faculty of Medicine
    Izmir, Turkey (Türkiye)
    Recruiting
  • Department of Cardiovascular Surgery, Faculty of Medicine, Recep Tayyip Erdoğan University
    Rize, Turkey (Türkiye)
    Recruiting
  • Department of Cardiac Surgery
    Coswig, Germany
    Active not recruiting
Show 7 more locations
  • Department of Thoracic and Cardiovascular Surgery, University Medical Centre Goettingen
    Göttingen, Germany
    Active not recruiting
  • Department of Cardiothoracic and Vascular Surgery, Ulm University Hospital
    Ulm, Germany
    Completed
  • Department of Cardiac Surgery GVM Maria Eleonora Hospital
    Palermo, Italy
    Active not recruiting
  • Department of Cardiovascular Surgery, Ankara City Hospital
    Ankara, Turkey (Türkiye)
    Active not recruiting
  • Department of Cardiac Surgery, Royal Papworth Hospital
    Cambridge, United Kingdom
    Active not recruiting
  • Deparment of Cardiac Surgery, Castle Hill Hospital
    Hull, United Kingdom
    Active not recruiting
  • Department of Cardiothoracic Surgery, Hammersmith Hospital
    London, United Kingdom
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.